Phyton Biotech is a pharmaceutical R&D/mfg company specializing in Plant Cell Fermentation (PCF®) technology to create drugs that treat cancer & other diseases.
As a biotechnology leader with certified GMP facilities in Germany and Canada, @PhytonBiotech has a successful track record of developing and implementing innovative contract development solutions for clients around the world using PCF®.ow.ly/gx8R30nxbPv#plantcellculture
@PhytonBiotech announces exclusive partnership with PellePharm to develop renewable supply of cyclopamine, key ingredient in PellePharm’s investigational topical therapy for Gorlin Syndrome using our Plant Cell Fermentation (PCF®) technology. ow.ly/VZpS30nx4tp#biotech
PCF®, @PhytonBiotech's award-winning, environmentally responsible #biotech solution is ideally suited for the development of phytochemicals at commercial scale across the #pharma, Chinese medicine, cosmetic, agricultural and food ingredient industries ow.ly/m6mL30nwb5R
With a mission to develop and produce APIs and other high-value plant-based compounds via our proprietary “green” PCF®, @PhytonBiotech is an industry leader in plant cell culture development. Learn more about the PCF® process: ow.ly/el5330mJm8O#biotech#pharmaceutical
@PhytonBiotech has the capacity to meet more than one-third of global demand for paclitaxel and docetaxel. Learn how we use our green PCF® technology to produce high-quality, sustainably produced taxane APIs: bit.ly/2RowP9y#biotech#pharma#Paclitaxel#Docetaxel
Did you know @PhytonBiotech operates the world’s largest cGMP plant cell fermentation facility with more than 200,000 litres of fermentation capacity and multiple production lines from kilograms to tonnes of product volumes? Learn more: bit.ly/2BBDGGR#biotech#plantcell
Did you know @PhytonBiotech revolutionized the manufacturing process for paclitaxel (one of the world’s most important anti-cancer drugs) from plant cell cultures using PCF®?
Read our case study here: ow.ly/yHNj30nmQL0
Our teams in Germany and Canada are uniquely qualified to carry out a full development program for plant-based compounds using our patented (PCF®) Technology, serving the pharmaceutical, Chinese Medicine, cosmetic, agricultural and food industries.
phytonbiotech.com
It's @PhytonBiotech's last day at @jpmorgan's Health Care Conference in San Francisco.
Connect with us to discuss how plant cell fermentation technology (PCF®) can support your unique project needs for high quality plant-derived actives.
ow.ly/Gbhp30ndRNQ#jpmhc19
Did you know!? @PhytonBiotech is developing a new production method for QS-21 using plant cell cultures? Through R&D led by @Agenus_Bio & funded by @gatesfoundation Our PCF® technology will ensure continuous supply of the critical vaccine ingredient. ow.ly/ReA230nbfml
Today marks the start of the 37th Annual @jpmorgan Health Care Conference in San Francisco. We look forward to meeting with you and discussing how our plant cell fermentation technology can support your project needs. Learn more here: ow.ly/Gbhp30ndRNQ#conference#jpmorgan
This project is the second R&D study affiliated with @gatesfoundation in which @PhytonBiotech is attempting to demonstrate that PCF® is a feasible alternative model for the consistent, large-scale, low-cost and commercial production of high-quality phytochemicals. #biotech
Our Plant Cell Fermentation (PCF®) technology offers "green" advantages over other commercial production methods for #phytochemicals. PCF® is ideal for replacing extraction from wild slow-growing, endangered or environmentally sensitive native plant species or cultivated biomass.
This project is the second R&D study affiliated with @gatesfoundation in which @PhytonBiotech is attempting to demonstrate that PCF® is a feasible alternative model for the consistent, large-scale, low-cost and commercial production of high-quality #phytochemicals.